Company intelligence

INBS

Intelligent Bio Solutions Inc. · NASDAQ · Healthcare

Price$2.26-4.24% · −$0.10

Market cap1.46MEquity value

P / E-0.2Trailing ratio

Volume45.1KLatest session

Market data

INBS price chart

TradingView

Related signals

1 min delayed

Browse public INBS signals with their source context and measured market impact. Open any signal for its permanent analysis page.

INBSAug 17, 2026-4.45% since signal

INBS rises on regulatory milestone for rapid testing unit

Intelligent Bio Solutions announced a regulatory milestone for its rapid testing unit, sparking a Monday afternoon stock surge. The milestone could hasten regulatory clearance and commercialization, offering near-term upside if the unit gains market access. No revenue or margin details were provided, so investors should look for additional disclosures.

View signal analysis

INBSDec 31, 2025+8.91% since signal

Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts

INBS announces partnership with Syrma Johari MedTech for manufacturing. Partnership expected to improve gross margins by 20 percentage points. New capacity four times current levels supports future demand. Annual production cost savings anticipated to exceed 40%. Substantial volume increase indicates strong market interest.

View signal analysis

Research